<DOC>
	<DOC>NCT02752087</DOC>
	<brief_summary>This study of healthy participants will evaluate the concentration of a test LY900014 and a reference LY900014 formulation in the bloodstream and how it affects the blood sugar levels. The whole study, including screening, will take up to 8 weeks to complete.</brief_summary>
	<brief_title>A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Female participants who can potentially get pregnant: Must have a negative pregnancy test at the time of screening Agree to continue to use a reliable method of birth control until the end of the study Have a body mass index (BMI) of 18.0 to 30.0 kilogram per meter square (kg/mÂ²), inclusive, at screening Are nonsmokers, have not smoked for at least 2 months before entering the study Are currently enrolled in a clinical trial involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study Have known allergies to insulin lispro, related compounds, or any components of the formulation Have significant history of or current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, or neurological disorders capable of significantly altering the absorption, metabolism, or elimination of drugs Intend to use overthecounter or prescription medication within 7 and 14 days, respectively, before dosing (apart from vitamin/mineral supplements, occasional paracetamol, hormonal contraception, or thyroidreplacement therapy) Have used systemic glucocorticoids within 3 months prior to entry into the study Have donated blood of more than 450 milliliters (mL) or more in the last 3 months or provided any blood donation within the last month before screening</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>